CytRx Owners | StatInvestor

Health Care & Life Sciences » Biotechnology | CytRx Corp.

CytRx Corp. | Ownership

Companies that own CytRx Corp.

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Sabby Capital LLC

1,674,431

4.98%

1,674,431

0.93%

06/30/2018

The Vanguard Group, Inc.

795,401

2.37%

45,021

06/30/2018

BlackRock Fund Advisors

297,948

0.89%

67,844

06/30/2018

Geode Capital Management LLC

186,584

0.56%

29,931

06/30/2018

Virtu Financial BD LLC

102,241

0.3%

69,670

0.01%

06/30/2018

D. E. Shaw & Co. LP

69,964

0.21%

-75,822

06/30/2018

Northern Trust Investments, Inc.

51,433

0.15%

8,494

06/30/2018

A.R.T. Advisors LLC

36,386

0.11%

36,386

06/30/2018

Dimensional Fund Advisors LP

25,747

0.08%

06/30/2018

The California Public Employees Retirement System

22,217

0.07%

06/30/2018

About CytRx

View Profile

Address	11726 San Vicente Boulevard Los Angeles California 90049 United States
Employees	-
Website	http://www.cytrx.com
Updated	07/08/2019
CytRx Corp. operates as a biopharmaceutical research and development company specializing in oncology. It focuses on discovering, developing, and commercializing new therapeutics to treat patients with cancer; including aldoxorubicin, a modified version of the widely-used chemotherapeutic agent, doxorubicin. The company was founded on February 28, 1985 and is headquartered in Los Angeles, CA.